Equity

BGF World Healthscience Fund

Overview

Important Information: Capital at Risk. All financial investments involve an element of risk. Therefore, the value of your investment and the income from it will vary and your initial investment amount cannot be guaranteed.


Important Information:
Investors must read the Prospectus for any fund in which they wish to invest. Please contact us at the BlackRock Advisors UK Limited-Dubai Branch for the relevant Prospectus.
Show Fewer
Loading

Performance

Performance

  • Returns

Performance is not shown as the Fund has a performance history of less than 1 year
Missing average annual returns data
Missing cumulative returns data

The figures shown relate to past performance. Past performance is not a reliable indicator of future results and should not be the sole factor of consideration when selecting a product or strategy.

Share Class and Benchmark performance displayed in EUR, hedged fund benchmark performance is displayed in USD.

Performance is shown on a Net Asset Value (NAV) basis, with gross income reinvested where applicable. The return of your investment may increase or decrease as a result of currency fluctuations if your investment is made in a currency other than that used in the past performance calculation. Source: Blackrock

Chart

Performance chart data not available for display.
View full chart

Reinvestments

This product does not have any distributions data as of now.

Key Facts

Key Facts

Size of Fund (Millions) as of 18-Apr-2019 USD 3,873.812
Base Currency USD
Fund Launch Date 06-Apr-2001
Share Class launch date 17-Apr-2019
Asset Class Equity
Morningstar Category -
Benchmark Index -
Domicile Luxembourg
Regulatory Structure UCITS
Management Company -
ISIN LU1960224654
Bloomberg Ticker BGWHAI2
Initial Charge 5.00%
Performance Fee -
SEDOL BHL2VJ9
Bloomberg Benchmark Ticker -
Dealing Settlement Trade Date + 3 days
Dealing Frequency Daily, forward pricing basis
Minimum Initial Investment EUR 25000
Minimum Subsequent Investment EUR 1000
Use of Income Accumulating

Risk Indicator

Risk Indicator

1
2
3
4
5
6
7
Low Risk High Risk
Typically low rewards Typically high rewards

Ratings

Holdings

Holdings

as of 29-Mar-2019
Name Weight (%)
ABBOTT LABORATORIES 5.51
UNITEDHEALTH GROUP INC 4.91
PFIZER INC 4.46
MERCK & CO INC 4.33
BOSTON SCIENTIFIC CORP 4.20
Name Weight (%)
ROCHE HOLDING PAR AG 3.96
ASTRAZENECA PLC 3.75
NOVARTIS AG 3.66
NOVO NORDISK CLASS B 3.04
SANOFI SA 2.97
Holdings subject to change

Pricing & Exchange

Investor Class Currency Distribution Frequency NAV NAV Amount Change NAV % Change 52wk High 52wk Low Bid Price ISIN Offer Price TIS
Class AI2 EUR - - - - - - - LU1960224654 - -
Class A2 EUR None 37.05 -0.49 -1.31 40.42 31.88 - LU0171307068 - -
Class D2 EUR None 40.40 -0.54 -1.32 44.07 34.51 - LU0827889485 - -
Class D4 USD Annual 10.40 -0.20 -1.89 11.45 9.66 - LU1728553774 - -
Class D2 USD None 45.45 -0.83 -1.79 50.03 42.05 - LU0329593007 - -
Class A2 USD None 41.67 -0.77 -1.81 46.06 38.83 - LU0122379950 - -

Portfolio Managers

Portfolio Managers

Erin Xie
Erin Xie

Literature

Literature